Baxter International (BAX) Depreciation & Amortization (CF) (2009 - 2026)
Baxter International (BAX) reported Depreciation & Amortization (CF) of $237.0 million for Q1 2026, down 4.05% year-over-year from $247.0 million in Q1 2025, and down 1.25% quarter-over-quarter from $240.0 million in Q4 2025.
Baxter International (BAX) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Depreciation & Amortization (CF) data on file, last reported at $237.0 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $237.0 million, down 4.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $971.0 million (changed 0.21% YoY), and the FY2025 annual result was $981.0 million, down 1.6% from the prior year.
- Depreciation & Amortization (CF) declined to $237.0 million in Q1 2026 per BAX's latest filing, from $240.0 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $380.0 million in Q1 2022 and troughed at $18.0 million in Q4 2022.
- A 5-year average of $251.2 million and a median of $254.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) slumped 91.89% in 2022, then surged 1366.67% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $18.0 million in 2022, then surged by 1366.67% to $264.0 million in 2023, then dropped by 7.2% to $245.0 million in 2024, then declined by 2.04% to $240.0 million in 2025, then declined by 1.25% to $237.0 million in 2026.
- Business Quant data shows BAX's Depreciation & Amortization (CF) at $237.0 million in Q1 2026, $240.0 million in Q4 2025, and $237.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 64.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237.00 Mn |
| Mar 31, 2026 | 237.00 Mn |
| Dec 31, 2025 | 240.00 Mn |
| Dec 31, 2025 | 240.00 Mn |
| Sep 30, 2025 | 237.00 Mn |
| Sep 30, 2025 | 237.00 Mn |
| Jun 30, 2025 | 257.00 Mn |
| Jun 30, 2025 | 257.00 Mn |
| Mar 31, 2025 | 247.00 Mn |
| Mar 31, 2025 | 247.00 Mn |
| Dec 31, 2024 | 245.00 Mn |
| Dec 31, 2024 | 245.00 Mn |
| Sep 30, 2024 | 254.00 Mn |
| Sep 30, 2024 | 254.00 Mn |
| Jun 30, 2024 | 227.00 Mn |
| Jun 30, 2024 | 227.00 Mn |
| Mar 31, 2024 | 271.00 Mn |
| Mar 31, 2024 | 271.00 Mn |
| Dec 31, 2023 | 264.00 Mn |
| Dec 31, 2023 | 264.00 Mn |